Calcitonin Levels in Patients with Thyroid Nodules, ETA,
Clinician Competencies for Cancer Self-Management Support, MASCC,
Frontline Targeted Therapy in Chronic Lymphocytic Leukaemia, Italian CLL Delphi Panel,
NF1 Peripheral Nerve Sheath Tumours at Risk for Malignant Transformation, Atypical Neurofibroma Symposium,
When Cord Blood May Be the Preferred Donor Source, ASTCT,
Prostate Cancer Early Detection, ACS,
Management of Chronic Graft-versus-Host Disease, Spanish cGVHD Panel,
Measurable Residual Disease in Acute Lymphoblastic Leukaemia, International ALL Study Groups,
Prostate MRI in the New S3 Prostate Cancer Guideline, DRG/BDR,
Recurrent or Metastatic Nasopharyngeal Carcinoma, CSCO/ASCO,
Stage IB–III Nasopharyngeal Carcinoma, CSCO/ASCO,
Cryopreservation of Academic CAR T-Cell Products, EBMT,
Managing Rheumatological Disease and Cancer, AIOM/SIR,
Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms, ENETS,
Immunotherapy for Multiple Myeloma, SITC,
Advanced Mycosis Fungoides and Sézary Syndrome, EHA/EORTC/ISCL/EBMT,
Clinical Breast Examination in Breast Cancer Screening, CNGOF,
Establishing and Operating Cancer Registries, WHO SEARO/SEACanGrid,
Measurable Residual Disease in Adult Acute Lymphoblastic Leukaemia, APLC,
Palliative Care for Adults With Grade 3 or 4 Gliomas, Italian Guideline Group,
Superficial Radiation Therapy Using Low-Energy Kilovoltage X-Rays, AAPM,
Advanced NSCLC With Comorbidities and Frailty, UK Expert Consensus Group,
Management of Cervical Cancer, French Cervical Cancer Guidelines Group,
Stage IV Non-Small-Cell Lung Cancer With Driver Alterations, ASCO,
Hypofractionated Radiation Therapy for Localized Prostate Cancer, ASTRO,
PARP Inhibitors in Ovarian Cancer, ASCO,
Early Detection and Referral of Gastrointestinal Cancer, AMG,
High-Risk and Recurrent Prostate Cancer, APCCC,
Palliative Care in Haematopoietic Cell Transplantation and Cellular Therapy, EBMT,
Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma, DDG/ADO,
Low-Grade Serous Ovarian Cancer, LGSOC Consensus Conference,
Cardiovascular Magnetic Resonance in Cardio-Oncology, SCMR/IC-OS,
HER2 Testing in Gastroesophageal Adenocarcinoma, CAP/ASCP/ASCO,
Planning and Delivering Lung-Cancer Reirradiation, ESTRO/ReCOG,
Spatially Fractionated Radiation Therapy, ESTRO,
Pancreatic Enzyme Replacement in Pancreatic Cancer, Canopy/PanCAN,
Perioperative FLOT for Resectable Gastric and GEJ Cancer, International Expert Panel,
Gastric and Oesophageal Cancer, ESMO,
Imaging and Initial Management of Retroperitoneal Sarcomas, CAR/CSAR,
Infection Prophylaxis in Patients With Cancer, SEOM/GGCC,
Management of Myelofibrosis in Adults, ASH,
Treatment of Advanced Biliary Tract Cancer, ASCO,
Metabolic Bariatric Surgery for Cancer Prevention, IFSO,
Preventing Acute Radiation Dermatitis With Barrier-Forming Topical Agents, MASCC,
Liver Transplantation for Advanced Small-Intestinal and Pancreatic NETs, ENETS,
Pancreatic Cyst and HCC Surveillance in Older Adults, AGA,
Serrated Polyposis Syndrome, ACG/AGA/ASGE,
Early Detection of Oral Squamous Cell Carcinoma, ADA (Dental),
Radiotherapy for Pituitary Adenomas, Pituitary Society,
CAP Cancer Protocols: September 2026 Update, CAP,
Esophageal and Esophagogastric Junction Cancers, NCCN,
Therapeutic Apheresis in Clinical Practice, ASFA,
Radiation Therapy for Bladder Cancer, ASTRO,
WHO Classification of Genetic Tumour Syndromes, WHO/IARC,
Connectome MRI and Clinical Data Protocols for Stroke, Parkinson's Disease, and Glioma, EAN,
Seasonal Respiratory Virus Vaccines in Immunocompromised Patients, IDSA,
Liquid Biopsy in Solid Tumours, ESP,
Medical Therapy for HR-Positive, HER2-Negative Early Breast Cancer, ASCO,
Primary Mediastinal B-Cell Lymphoma, BSH,
Cutaneous Toxicities of T-Cell-Redirecting Therapies in Multiple Myeloma, EADV,
Daraxonrasib for Metastatic Pancreatic Cancer, ESMO,
Advanced Gastroesophageal Cancer: Immunotherapy and Targeted Therapy, ASCO,
Cancer Survivorship, NCCN,
Stage IV NSCLC With Driver Alterations, ASCO,
Levodopa and Melanoma in Parkinson's Disease, MDS,
Radiation Therapy for Pancreatic Cancer, ASTRO,
Systemic Therapy for Metastatic Castration-Resistant Prostate Cancer, ASCO,
AGA Clinical Practice Update on Surveillance of Metaplastic and Premalignant Conditions of the Esophagus and Colorectum in Older Adults: Expert Review, AGA,
WHO Classification of Digestive System Tumours, WHO/IARC,
Lung Cancer Screening in Older Adults, SIOG,
Diagnosis of Light Chain Amyloidosis, ASH,
Optimising Prostate Stereotactic Body Radiotherapy, ESTRO,
International Classification of Diseases for Oncology, Fourth Edition, WHO/IARC,
High-Dose Thoracic Reirradiation for NSCLC, ESTRO,
Breast Cancer Follow-Up and Surveillance, ASCO,
Systemic Treatment of Recurrent Ovarian Cancer, ASCO,
Myeloproliferative Neoplasms, NCCN,
Focal Boost in Prostate Cancer Radiotherapy, ESTRO,
Frontline Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults, ASH,
Reirradiation for Locally Recurrent Rectal Cancer, ESTRO (ASTRO-endorsed),
Treatment of Multiple Myeloma, ASCO,
Diagnosis, Treatment and Follow-Up of Hodgkin Lymphoma, EHA,
Sublobar Resection in Early-Stage Non-Small Cell Lung Cancer, STS,
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma, ASCO,
Acute Myeloid Leukemia, NCCN,
Cardiovascular Endpoints in Oncology Trials, AHA,
Management of Chronic Lymphocytic Leukemia and Richter Transformation, EHA,
Enhanced Recovery After Surgery in Gynecologic Oncology: 2026 Update, ERAS Society,
Exercise During and After Cancer Treatment in Children and Adolescents, ACSM,
Cardiovascular Disease in Adults With Cancer, IC-OS/MASCC,
Metastatic Breast Cancer, ESMO,
Stage IV NSCLC Without Driver Alterations, ASCO,
British Thoracic Society Quality Standard for Pleural Disease, BTS,
ERS/ESGE/ESTS clinical practice guidelines on endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer, ERS/ESGE/ESTS,
Prostate Cancer, NCCN,
Early Diagnosis of Light Chain Amyloidosis, BSH,
Invasive Cutaneous Squamous Cell Carcinoma: Diagnosis and Prevention, EADO/EDF/ESTRO/UEMS-DV/EORTC,
Treatment of Invasive Cutaneous Squamous Cell Carcinoma, EADO/EDF/ESTRO/UEMS-DV/EORTC,
Multimodal Treatment of Pleural Mesothelioma, STS,
Breast Cancer Screening in Average-Risk Adult Females, ACP,
Clinically Localized Prostate Cancer, AUA/ASTRO,
Radiotherapy for Adult Soft Tissue Sarcoma, ESTRO (ASTRO-endorsed),
Transvaginal Ultrasonography for Postmenopausal Bleeding, ACOG,
AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review, AGA,
Screening for Cervical Cancer, ACOG,
Metastatic Colorectal Cancer, ESMO,
Topical Corticosteroids for Acute Radiation Dermatitis, MASCC,
Distress Management in Cancer Care, NCCN,
Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC, IASLC,
Uveal Melanoma, ESMO/EURACAN,
Diagnosis and Management of Severe Acquired Aplastic Anemia, ASH,
Radiotherapy for Stage I–III Small Cell Lung Cancer, ESTRO/EORTC,
Systemic Treatment of Thyroid Cancer, ASCO,
Immunotherapy for Renal Cell Carcinoma, SITC,
2026 Prostate Cancer Guideline, EAU/EANM/ESTRO/ESUR/ISUP/SIOG,
Cancer in Pregnancy, SMFM,
Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, NCCN,
Patient-Clinician Communication in Cancer Care, ASCO,
Combining Radiotherapy With EGFR, ALK, or BRAF/MEK Inhibitors, ESMO/ESTRO,
White Blood Cell Growth Factors, ASCO,
Rectal Cancer Target Delineation and Dose Escalation, ESTRO,
WHO Reporting System for Soft Tissue Cytopathology, IAC/IARC/WHO,
AGA Clinical Practice Update on Management of Gastric Polyps: Expert Review, AGA,
Relapsed or Refractory Acute Lymphoblastic Leukemia in Adolescents and Young Adults, ASH,
Advanced and Metastatic Prostate Cancer, ESMO,
Coronary Atherosclerosis in Patients With Cancer and Survivors, AHA,
Hereditary Risk Assessment for Breast, Ovarian, Pancreatic, and Prostate Cancers, NCCN,
IMRT and Image Guidance for Rectal Cancer, ESTRO,
Interventions for Screen-Detected Lung Nodules, STS,
Positive hCG Results in Nonpregnant Patients Without Gynecologic Malignancy, ACOG,
Management of Epithelial Ovarian Cancer, ESMO,
Physical Exercise in Localized Colon Cancer, ESMO,
WHO Classification of Eye and Orbit Tumours, WHO/IARC,
Dose Constraints for Radiation Treatment Planning, ASTRO,
Small Cell Lung Cancer, NCCN,
Local and Regional Analgesia for Major Truncal Surgery, ASA,
Targeted Therapy in Inflammatory Arthritis After Cancer, EULAR,
Perioperative Venous Thromboembolism Prophylaxis, ESAIC and partner societies,
